Polymer hydrogel adhesives formed with multiple crosslinking mechanisms at physiologic ph

Abstract

The present invention encompasses biocompatible reactants, biocompatible product hydrogels, methods of use thereof, and methods of synthesis thereof using a novel crosslinking mechanism between a first reactant compound including an N-Hydroxysuccinimide (NHS) ester group and a second reactant compound including a N-terminal cysteine amine group. In certain embodiments, one or more of the reactant compounds may be a macromonomer.

1 . A hydrogel obtained by covalently cross-linking a first macromonomer comprising an N-Hydroxysuccinimide (NHS) ester group with a second macromonomer comprising a N-terminal cysteine group. 
     
     
         2 . The hydrogel of  claim 1  wherein covalently cross-linking the first and second macromonomers comprises:
 (a) forming an amide bond between the carboxyl carbon of the N-Hydroxysuccinimide (NHS) ester group of the first macromonomer and the primary amine of the N-terminal cysteine group of the second macromonomer to form a third macromonomer, and 
 (b) forming a disulfide bond between primary thiol groups on two of the third macromonomers produced in step (a). 
 
     
     
         3 . The hydrogel of  claim 1  wherein the hydrogel is biocompatible. 
     
     
         4 . The hydrogel of  claim 1  wherein the first macromonomer, the second macromonomer, or both, comprise polyethylene glycol. 
     
     
         5 . The hydrogel of  claim 4 , wherein the second macromonomer further comprises a catechol group. 
     
     
         6 . The hydrogel of  claim 1 , wherein the first macromonomer is selected from the group consisting of: 
       
         
           
           
               
               
           
         
         and wherein the second macromonomer comprises the chemical structure: 
       
       
         
           
           
               
               
           
         
       
     
     
         7 . The hydrogel of  claim 6 , wherein each n has a value in the range of from 1 to 201, and wherein each R comprises a hexaglycerin core or a tripentaerythritol core. 
     
     
         8 . A method of synthesizing a hydrogel comprising covalently cross-linking an effective amount of a first macromonomer comprising an N-Hydroxysuccinimide (NHS) ester group with an effective amount of a second macromonomer comprising a N-terminal cysteine group, wherein a hydrogel is formed. 
     
     
         9 . The method of  claim 8 , wherein the step of covalently cross-linking the first and second macromonomers comprises:
 (a) forming an amide bond between the carboxyl carbon of the N-Hydroxysuccinimide (NHS) ester group of the first macromonomer and the primary amine of the N-terminal cysteine group of the second macromonomer to form a third macromonomer, and   (b) forming a disulfide bond between primary thiol groups on two of the third macromonomers produced in step (a).   
     
     
         10 . The method of  claim 8 , wherein the hydrogel formed is biocompatible. 
     
     
         11 . The method of  claim 8 , wherein the step of covalently cross-linking the first and second macromonomers occurs at physiological pH. 
     
     
         12 . The method of  claim 8 , wherein the first macromonomer, the second macromonomer, or both, comprise polyethylene glycol. 
     
     
         13 . The method of  claim 8 , wherein the second macromonomer further comprises a catechol group. 
     
     
         14 . The method of  claim 8 , wherein the first macromonomer is selected from the group consisting of: 
       
         
           
           
               
               
           
         
         and wherein the second macromonomer comprises the chemical structure: 
       
       
         
           
           
               
               
           
         
       
     
     
         15 . The method of  claim 14 , wherein each n has a value in the range of from 1 to 201, and wherein each R comprises a hexaglycerin core or a tripentaerythritol core. 
     
     
         16 . A kit for synthesizing a biocompatible hydrogel comprising:
 (a) a first macromonomer comprising an N-Hydroxysuccinimide (NHS) ester group; and   (b) a second macromonomer comprising a N-terminal cysteine group.   
     
     
         17 . The kit of  claim 16 , wherein the first macromonomer, the second macromonomer, or both, comprise polyethylene glycol. 
     
     
         18 . The kit of  claim 16 , wherein the first macromonomer is selected from the group consisting of: 
       
         
           
           
               
               
           
         
         and wherein the second macromonomer is a macromonomer comprising the chemical structure: